The National Institute of Mental Health offers grants to explore novel smoking cessation treatments for individuals with schizophrenia and implementation strategies for existing treatments. This funding opportunity aims to support research that will provide valuable insights into intervention development and implementation in individuals with schizophrenia and co-occurring substance abuse disorders. Grants under this program will be funded for up to 3 years and will focus on a variety of intervention approaches, including behavioral, pharmacological, and physiological methods.
Opportunity ID: 255489
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-231 |
Funding Opportunity Title: | Exploratory Studies of Smoking Cessation Interventions for People with Schizophrenia (R33) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.242 — Mental Health Research Grants |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 19, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | Apr 17, 2017 |
Current Closing Date for Applications: | Apr 17, 2017 |
Archive Date: | May 18, 2017 |
Estimated Total Program Funding: | $3,500,000 |
Award Ceiling: | $225,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Native American tribal governments (Federally recognized) Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Independent school districts For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public housing authorities/Indian housing authorities County governments City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The purpose of this Funding Opportunity Announcement (FOA) is to provide support for grant applications of two major types. Type I will conduct exploratory testing of novel, targeted treatments for smoking cessation for individuals with schizophrenia. Type II will conduct exploratory testing of targeted implementation strategies of existing efficacious treatments at the service-delivery system level. Smokers with schizophrenia who have co-occurring alcohol and/or substance abuse disorders are also a population of interest. Under this FOA, trials should be designed so that results, whether positive or negative, will provide information of high scientific utility and will support decisions about further development or testing of interventions or implementation strategies. Studies of novel interventions include, but are not limited to behavioral, pharmacological, biologics-based, cognitive, device-based, interpersonal, physiological, or combined approaches. The R33 funding mechanism provides support for up to 3 years, for either application type. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-231.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | Forms-C | PKG00196884 | Jul 15, 2014 | Jun 07, 2016 | View | |
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00223984 | Jul 16, 2016 | Apr 17, 2017 | View |
Package 1
Mandatory forms
255489 RR_SF424_2_0-2.0.pdf
255489 PHS398_ResearchPlan_2_0-2.0.pdf
255489 PHS398_CoverPageSupplement_2_0-2.0.pdf
255489 RR_Budget_1_3-1.3.pdf
255489 RR_KeyPersonExpanded_2_0-2.0.pdf
255489 RR_OtherProjectInfo_1_3-1.3.pdf
255489 PerformanceSite_2_0-2.0.pdf
Optional forms
255489 PlannedReport-1.0.pdf
255489 PHS398_CumulativeInclusionReport-1.0.pdf
255489 RR_SubawardBudget30_1_3-1.3.pdf
Package 2
Mandatory forms
255489 RR_SF424_2_0-2.0.pdf
255489 PHS398_CoverPageSupplement_3_0-3.0.pdf
255489 RR_OtherProjectInfo_1_3-1.3.pdf
255489 PerformanceSite_2_0-2.0.pdf
255489 RR_KeyPersonExpanded_2_0-2.0.pdf
255489 RR_Budget_1_3-1.3.pdf
255489 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
255489 RR_SubawardBudget30_1_3-1.3.pdf
255489 PHS_Inclusion_Enrollment_Report-1.0.pdf
255489 PHS_AssignmentRequestForm-1.0.pdf